| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Klebsiella pneumoniae | 10 | 2025 | 80 | 3.460 |
Why?
|
| Bacterial Proteins | 14 | 2025 | 947 | 2.730 |
Why?
|
| Klebsiella Infections | 9 | 2025 | 57 | 2.660 |
Why?
|
| Virulence Factors | 8 | 2025 | 180 | 2.470 |
Why?
|
| Gene Expression Regulation, Bacterial | 10 | 2025 | 166 | 2.430 |
Why?
|
| Yersinia enterocolitica | 7 | 2016 | 10 | 1.830 |
Why?
|
| Bacterial Capsules | 3 | 2020 | 42 | 1.230 |
Why?
|
| Nursing Staff, Hospital | 4 | 2014 | 65 | 1.150 |
Why?
|
| Physicians | 8 | 2024 | 629 | 1.120 |
Why?
|
| Medical Staff, Hospital | 2 | 2025 | 91 | 1.000 |
Why?
|
| Relaxation | 1 | 2025 | 3 | 0.920 |
Why?
|
| Rest | 1 | 2025 | 64 | 0.890 |
Why?
|
| Yersinia Infections | 2 | 2016 | 7 | 0.870 |
Why?
|
| Host-Pathogen Interactions | 2 | 2026 | 253 | 0.820 |
Why?
|
| Attitude of Health Personnel | 7 | 2025 | 704 | 0.820 |
Why?
|
| Pandemics | 6 | 2025 | 1115 | 0.720 |
Why?
|
| Bacterial Infections | 1 | 2025 | 327 | 0.710 |
Why?
|
| Career Choice | 7 | 2020 | 165 | 0.710 |
Why?
|
| Organizational Culture | 5 | 2022 | 95 | 0.690 |
Why?
|
| State Medicine | 5 | 2026 | 23 | 0.680 |
Why?
|
| Bacteria | 1 | 2025 | 521 | 0.670 |
Why?
|
| Mucus | 1 | 2020 | 37 | 0.650 |
Why?
|
| Virulence | 6 | 2025 | 268 | 0.640 |
Why?
|
| Psychiatric Nursing | 2 | 2017 | 7 | 0.620 |
Why?
|
| Job Satisfaction | 4 | 2018 | 100 | 0.620 |
Why?
|
| Hypothermia | 3 | 2018 | 61 | 0.610 |
Why?
|
| Nurse's Role | 3 | 2016 | 35 | 0.600 |
Why?
|
| Career Mobility | 3 | 2026 | 52 | 0.590 |
Why?
|
| Needs Assessment | 2 | 2019 | 173 | 0.590 |
Why?
|
| Schools, Medical | 4 | 2024 | 113 | 0.580 |
Why?
|
| Operon | 3 | 2025 | 50 | 0.560 |
Why?
|
| Mobile Applications | 1 | 2019 | 113 | 0.530 |
Why?
|
| Self Care | 1 | 2019 | 231 | 0.520 |
Why?
|
| Humans | 72 | 2026 | 130611 | 0.520 |
Why?
|
| United Kingdom | 13 | 2026 | 265 | 0.510 |
Why?
|
| Education, Medical, Continuing | 2 | 2018 | 130 | 0.500 |
Why?
|
| Interprofessional Relations | 2 | 2016 | 149 | 0.500 |
Why?
|
| Genes, Bacterial | 4 | 2020 | 214 | 0.500 |
Why?
|
| Hospitals, Private | 2 | 2014 | 23 | 0.490 |
Why?
|
| Type III Secretion Systems | 1 | 2016 | 2 | 0.490 |
Why?
|
| Shoulder Joint | 2 | 2016 | 32 | 0.480 |
Why?
|
| Qualitative Research | 7 | 2026 | 722 | 0.470 |
Why?
|
| Mutation | 8 | 2026 | 6080 | 0.470 |
Why?
|
| Pharmacogenetics | 3 | 2022 | 201 | 0.470 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 153 | 0.460 |
Why?
|
| Curriculum | 3 | 2025 | 797 | 0.440 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2014 | 10 | 0.430 |
Why?
|
| Physician Assistants | 2 | 2026 | 81 | 0.430 |
Why?
|
| Chronic Disease | 1 | 2019 | 1244 | 0.430 |
Why?
|
| Protein Kinases | 1 | 2016 | 312 | 0.430 |
Why?
|
| Efficiency, Organizational | 1 | 2014 | 56 | 0.420 |
Why?
|
| Scotland | 5 | 2026 | 24 | 0.400 |
Why?
|
| Genomics | 6 | 2025 | 1621 | 0.400 |
Why?
|
| Phenotype | 5 | 2026 | 4483 | 0.400 |
Why?
|
| Bacterial Secretion Systems | 1 | 2013 | 5 | 0.390 |
Why?
|
| Internationality | 1 | 2013 | 128 | 0.380 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 4663 | 0.380 |
Why?
|
| Telemedicine | 1 | 2019 | 525 | 0.370 |
Why?
|
| Population Health | 2 | 2024 | 35 | 0.370 |
Why?
|
| Macrophages | 3 | 2026 | 664 | 0.370 |
Why?
|
| Arthroscopy | 1 | 2012 | 46 | 0.360 |
Why?
|
| New South Wales | 4 | 2014 | 12 | 0.350 |
Why?
|
| Medicine | 3 | 2022 | 100 | 0.350 |
Why?
|
| Workplace | 5 | 2021 | 80 | 0.350 |
Why?
|
| Patient Care Team | 2 | 2026 | 560 | 0.350 |
Why?
|
| Robotic Surgical Procedures | 2 | 2025 | 224 | 0.340 |
Why?
|
| Venous Thromboembolism | 1 | 2013 | 193 | 0.330 |
Why?
|
| Hospitals, Public | 1 | 2010 | 48 | 0.320 |
Why?
|
| Education, Medical, Graduate | 4 | 2019 | 552 | 0.320 |
Why?
|
| Escherichia coli | 3 | 2026 | 985 | 0.320 |
Why?
|
| Viscosity | 2 | 2020 | 37 | 0.310 |
Why?
|
| Australia | 4 | 2017 | 172 | 0.310 |
Why?
|
| Quality of Health Care | 3 | 2017 | 413 | 0.300 |
Why?
|
| Animals | 13 | 2026 | 33743 | 0.300 |
Why?
|
| Anti-Bacterial Agents | 5 | 2025 | 2580 | 0.300 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 1262 | 0.290 |
Why?
|
| Interviews as Topic | 4 | 2025 | 464 | 0.290 |
Why?
|
| Female | 34 | 2026 | 70631 | 0.290 |
Why?
|
| Education, Medical | 2 | 2023 | 291 | 0.290 |
Why?
|
| Professional Role | 3 | 2025 | 78 | 0.290 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 1362 | 0.280 |
Why?
|
| Caliciviridae Infections | 2 | 2025 | 286 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 1207 | 0.270 |
Why?
|
| Mice | 8 | 2026 | 18209 | 0.270 |
Why?
|
| Norovirus | 2 | 2025 | 285 | 0.270 |
Why?
|
| Specialization | 2 | 2019 | 75 | 0.270 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 787 | 0.270 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2025 | 396 | 0.260 |
Why?
|
| School Admission Criteria | 2 | 2018 | 31 | 0.260 |
Why?
|
| Nursing, Team | 1 | 2007 | 1 | 0.260 |
Why?
|
| Genome, Viral | 2 | 2025 | 165 | 0.250 |
Why?
|
| Virology | 2 | 2017 | 30 | 0.240 |
Why?
|
| Liver Abscess | 1 | 2025 | 13 | 0.230 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2026 | 90 | 0.230 |
Why?
|
| Male | 28 | 2026 | 64659 | 0.230 |
Why?
|
| Phenols | 1 | 2026 | 73 | 0.230 |
Why?
|
| Nurse Clinicians | 1 | 2005 | 5 | 0.230 |
Why?
|
| Glycolysis | 1 | 2026 | 173 | 0.230 |
Why?
|
| Perioperative Care | 2 | 2018 | 217 | 0.220 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2017 | 165 | 0.220 |
Why?
|
| Type VI Secretion Systems | 1 | 2025 | 2 | 0.220 |
Why?
|
| Genome, Bacterial | 2 | 2025 | 199 | 0.220 |
Why?
|
| beta-Lactams | 1 | 2024 | 56 | 0.210 |
Why?
|
| Adult | 19 | 2026 | 31146 | 0.210 |
Why?
|
| Escherichia coli Infections | 1 | 2026 | 194 | 0.210 |
Why?
|
| Mosaicism | 1 | 2026 | 247 | 0.200 |
Why?
|
| Educational Measurement | 2 | 2024 | 319 | 0.200 |
Why?
|
| Whole Genome Sequencing | 3 | 2026 | 361 | 0.200 |
Why?
|
| Philosophy, Nursing | 1 | 2003 | 3 | 0.200 |
Why?
|
| Acetaminophen | 1 | 2024 | 100 | 0.200 |
Why?
|
| Nursing Research | 1 | 2003 | 17 | 0.200 |
Why?
|
| Drug Hypersensitivity | 1 | 2024 | 101 | 0.200 |
Why?
|
| Colistin | 1 | 2023 | 30 | 0.200 |
Why?
|
| Genetic Loci | 1 | 2025 | 353 | 0.200 |
Why?
|
| Text Messaging | 1 | 2023 | 41 | 0.200 |
Why?
|
| Simulation Training | 1 | 2025 | 153 | 0.190 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2024 | 148 | 0.190 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2025 | 241 | 0.180 |
Why?
|
| Sequence Alignment | 2 | 2016 | 582 | 0.180 |
Why?
|
| Professional Practice Location | 2 | 2018 | 8 | 0.180 |
Why?
|
| Molecular Sequence Data | 4 | 2016 | 3461 | 0.180 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 33 | 0.180 |
Why?
|
| Self-Management | 1 | 2023 | 120 | 0.180 |
Why?
|
| Amaranthaceae | 1 | 2021 | 1 | 0.180 |
Why?
|
| Medicine, Traditional | 1 | 2021 | 7 | 0.180 |
Why?
|
| Plant Preparations | 1 | 2021 | 15 | 0.170 |
Why?
|
| Prospective Studies | 5 | 2021 | 6432 | 0.170 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 2392 | 0.170 |
Why?
|
| Women's Health | 1 | 2022 | 134 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2026 | 781 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2026 | 4661 | 0.160 |
Why?
|
| Disease Notification | 1 | 2020 | 10 | 0.160 |
Why?
|
| Spinal Cord Injuries | 1 | 2023 | 272 | 0.160 |
Why?
|
| Brain Stem Neoplasms | 1 | 2020 | 42 | 0.160 |
Why?
|
| Stress, Psychological | 2 | 2016 | 533 | 0.150 |
Why?
|
| Cinchona | 1 | 2019 | 1 | 0.150 |
Why?
|
| Plant Bark | 1 | 2019 | 4 | 0.150 |
Why?
|
| Protein Transport | 2 | 2013 | 366 | 0.150 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 314 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2023 | 393 | 0.150 |
Why?
|
| Chemoradiotherapy | 1 | 2020 | 125 | 0.150 |
Why?
|
| Cross Infection | 1 | 2023 | 336 | 0.150 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 108 | 0.150 |
Why?
|
| Middle Aged | 12 | 2026 | 28454 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 645 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2026 | 629 | 0.150 |
Why?
|
| Health Personnel | 2 | 2021 | 539 | 0.150 |
Why?
|
| Software | 2 | 2022 | 733 | 0.150 |
Why?
|
| Rural Population | 1 | 2022 | 275 | 0.150 |
Why?
|
| Learning | 1 | 2022 | 354 | 0.150 |
Why?
|
| Dentistry | 1 | 2019 | 5 | 0.150 |
Why?
|
| Dental Prophylaxis | 1 | 2019 | 3 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2026 | 1105 | 0.150 |
Why?
|
| Clinical Competence | 3 | 2025 | 1046 | 0.150 |
Why?
|
| Pharyngitis | 1 | 2019 | 34 | 0.140 |
Why?
|
| Geographic Mapping | 1 | 2018 | 15 | 0.140 |
Why?
|
| Social Media | 1 | 2021 | 120 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2020 | 230 | 0.140 |
Why?
|
| Young Adult | 8 | 2026 | 10042 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2019 | 113 | 0.140 |
Why?
|
| Genotype | 3 | 2025 | 2590 | 0.140 |
Why?
|
| Intention | 1 | 2019 | 103 | 0.140 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 81 | 0.140 |
Why?
|
| User-Computer Interface | 1 | 2019 | 164 | 0.140 |
Why?
|
| Staff Development | 2 | 2010 | 50 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2025 | 1556 | 0.140 |
Why?
|
| Pneumonia, Bacterial | 1 | 2019 | 78 | 0.140 |
Why?
|
| Body Temperature Regulation | 1 | 2018 | 52 | 0.130 |
Why?
|
| Personnel Selection | 1 | 2018 | 80 | 0.130 |
Why?
|
| Cultural Diversity | 1 | 2018 | 81 | 0.130 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 17 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2002 | 993 | 0.130 |
Why?
|
| Academic Success | 1 | 2017 | 23 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 298 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2019 | 363 | 0.130 |
Why?
|
| Achievement | 1 | 2017 | 32 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 832 | 0.120 |
Why?
|
| Tantalum | 1 | 2016 | 7 | 0.120 |
Why?
|
| Humerus | 1 | 2016 | 16 | 0.120 |
Why?
|
| Sodium Chloride | 2 | 2009 | 89 | 0.120 |
Why?
|
| Residential Facilities | 1 | 2016 | 3 | 0.120 |
Why?
|
| Archives | 1 | 2016 | 3 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 1 | 2016 | 14 | 0.120 |
Why?
|
| Students, Medical | 2 | 2018 | 347 | 0.120 |
Why?
|
| Communications Media | 1 | 2016 | 5 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 373 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 3422 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 4700 | 0.120 |
Why?
|
| Joint Diseases | 1 | 2016 | 31 | 0.120 |
Why?
|
| Educational Status | 3 | 2023 | 278 | 0.120 |
Why?
|
| Health Occupations | 1 | 2016 | 32 | 0.120 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 254 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2019 | 766 | 0.120 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 213 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2019 | 401 | 0.120 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 280 | 0.120 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 27 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 58 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1059 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 2 | 2019 | 1688 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 1445 | 0.110 |
Why?
|
| Hospitals | 3 | 2026 | 434 | 0.110 |
Why?
|
| Internship and Residency | 3 | 2020 | 1221 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2016 | 365 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2026 | 6773 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 711 | 0.110 |
Why?
|
| Professional Autonomy | 2 | 2005 | 29 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 222 | 0.110 |
Why?
|
| Mental Health Services | 1 | 2017 | 284 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 394 | 0.100 |
Why?
|
| Aged | 9 | 2026 | 20917 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2019 | 761 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2026 | 1935 | 0.100 |
Why?
|
| Occupational Therapy | 1 | 2013 | 37 | 0.100 |
Why?
|
| Bacterial Load | 1 | 2013 | 34 | 0.100 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 89 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 2111 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 708 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 205 | 0.090 |
Why?
|
| Base Sequence | 4 | 2022 | 2727 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1486 | 0.090 |
Why?
|
| Therapeutic Irrigation | 1 | 2012 | 44 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2013 | 248 | 0.090 |
Why?
|
| Adolescent | 9 | 2026 | 20893 | 0.090 |
Why?
|
| Protein Binding | 1 | 2016 | 1649 | 0.090 |
Why?
|
| Salaries and Fringe Benefits | 2 | 2018 | 33 | 0.090 |
Why?
|
| Feces | 1 | 2015 | 718 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 303 | 0.090 |
Why?
|
| Hot Temperature | 1 | 2012 | 137 | 0.090 |
Why?
|
| Intraoperative Care | 1 | 2012 | 123 | 0.090 |
Why?
|
| Decision Making | 3 | 2019 | 714 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2025 | 398 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2025 | 849 | 0.090 |
Why?
|
| Elective Surgical Procedures | 1 | 2012 | 161 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2017 | 722 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 4058 | 0.080 |
Why?
|
| Focus Groups | 2 | 2026 | 239 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2017 | 707 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2013 | 386 | 0.080 |
Why?
|
| Gene Order | 1 | 2010 | 80 | 0.080 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 135 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 111 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 300 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2018 | 2403 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2020 | 5049 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2012 | 356 | 0.080 |
Why?
|
| Health Promotion | 1 | 2013 | 421 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2010 | 340 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 739 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 404 | 0.070 |
Why?
|
| Communication | 2 | 2021 | 540 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 913 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 970 | 0.070 |
Why?
|
| Cell Line | 1 | 2013 | 2550 | 0.070 |
Why?
|
| Child | 7 | 2026 | 26262 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 6168 | 0.060 |
Why?
|
| Models, Organizational | 1 | 2007 | 41 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2010 | 1570 | 0.060 |
Why?
|
| Social Class | 2 | 2018 | 214 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2024 | 15048 | 0.060 |
Why?
|
| England | 1 | 2026 | 59 | 0.060 |
Why?
|
| Mental Health | 2 | 2024 | 378 | 0.060 |
Why?
|
| Protein Stability | 1 | 2026 | 165 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2007 | 87 | 0.060 |
Why?
|
| Bacterial Adhesion | 1 | 2026 | 104 | 0.060 |
Why?
|
| Thiazoles | 1 | 2026 | 113 | 0.060 |
Why?
|
| Workload | 1 | 2007 | 151 | 0.060 |
Why?
|
| Education, Nursing, Continuing | 1 | 2005 | 20 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 84 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2005 | 43 | 0.060 |
Why?
|
| Risk Factors | 2 | 2024 | 11020 | 0.060 |
Why?
|
| Adaptive Clinical Trials as Topic | 1 | 2024 | 5 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2024 | 68 | 0.050 |
Why?
|
| Texas | 2 | 2026 | 3663 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2024 | 67 | 0.050 |
Why?
|
| Hospitalization | 1 | 2013 | 1946 | 0.050 |
Why?
|
| Professional Competence | 1 | 2005 | 97 | 0.050 |
Why?
|
| Haplotypes | 1 | 2026 | 517 | 0.050 |
Why?
|
| Narration | 1 | 2024 | 32 | 0.050 |
Why?
|
| Documentation | 1 | 2005 | 121 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2025 | 178 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2026 | 428 | 0.050 |
Why?
|
| Postal Service | 1 | 2003 | 11 | 0.050 |
Why?
|
| Models, Nursing | 1 | 2003 | 6 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17662 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2026 | 479 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2024 | 78 | 0.050 |
Why?
|
| Social Values | 1 | 2003 | 46 | 0.050 |
Why?
|
| Liver Failure, Acute | 1 | 2024 | 94 | 0.050 |
Why?
|
| Electronic Mail | 1 | 2003 | 41 | 0.050 |
Why?
|
| Family Practice | 1 | 2003 | 82 | 0.050 |
Why?
|
| Social Stigma | 1 | 2024 | 80 | 0.050 |
Why?
|
| Knowledge | 1 | 2003 | 47 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2026 | 292 | 0.050 |
Why?
|
| Phylogeny | 1 | 2025 | 689 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2080 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2025 | 307 | 0.050 |
Why?
|
| Integration Host Factors | 1 | 2002 | 1 | 0.050 |
Why?
|
| Factor For Inversion Stimulation Protein | 1 | 2002 | 1 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2025 | 209 | 0.050 |
Why?
|
| Leadership | 1 | 2005 | 254 | 0.050 |
Why?
|
| Politics | 1 | 2003 | 61 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 207 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2005 | 236 | 0.050 |
Why?
|
| Health Surveys | 1 | 2003 | 261 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 709 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2023 | 143 | 0.050 |
Why?
|
| Ethnobotany | 1 | 2021 | 1 | 0.040 |
Why?
|
| Ethnopharmacology | 1 | 2021 | 1 | 0.040 |
Why?
|
| Poland | 1 | 2021 | 18 | 0.040 |
Why?
|
| Ceremonial Behavior | 1 | 2021 | 5 | 0.040 |
Why?
|
| Insect Repellents | 1 | 2021 | 35 | 0.040 |
Why?
|
| Genome, Human | 2 | 2019 | 1320 | 0.040 |
Why?
|
| Alleles | 1 | 2026 | 1673 | 0.040 |
Why?
|
| Death | 1 | 2022 | 78 | 0.040 |
Why?
|
| Vertebrates | 1 | 2021 | 36 | 0.040 |
Why?
|
| Malawi | 1 | 2022 | 348 | 0.040 |
Why?
|
| Informed Consent | 1 | 2003 | 351 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2299 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2020 | 178 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 793 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 321 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 358 | 0.040 |
Why?
|
| Cinchona Alkaloids | 1 | 2019 | 2 | 0.040 |
Why?
|
| Epidemiological Monitoring | 1 | 2020 | 69 | 0.040 |
Why?
|
| Quinine | 1 | 2019 | 9 | 0.040 |
Why?
|
| Infant | 3 | 2024 | 13308 | 0.040 |
Why?
|
| Psychology, Social | 1 | 2019 | 1 | 0.040 |
Why?
|
| Psychology, Educational | 1 | 2019 | 2 | 0.040 |
Why?
|
| Alkaloids | 1 | 2019 | 36 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 69 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5184 | 0.040 |
Why?
|
| Individuality | 1 | 2019 | 40 | 0.040 |
Why?
|
| Education, Continuing | 1 | 2019 | 29 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1441 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2026 | 887 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 81 | 0.040 |
Why?
|
| Training Support | 1 | 2018 | 20 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 57 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 317 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 93 | 0.040 |
Why?
|
| Aptitude Tests | 1 | 2018 | 3 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 335 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2019 | 124 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 146 | 0.030 |
Why?
|
| Demography | 1 | 2019 | 236 | 0.030 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 107 | 0.030 |
Why?
|
| Liver | 1 | 2025 | 1789 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 525 | 0.030 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 97 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2018 | 225 | 0.030 |
Why?
|
| College Admission Test | 1 | 2017 | 6 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2019 | 164 | 0.030 |
Why?
|
| Palliative Care | 1 | 2022 | 443 | 0.030 |
Why?
|
| Gender Identity | 1 | 2018 | 76 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 422 | 0.030 |
Why?
|
| Body Temperature | 1 | 2018 | 126 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 371 | 0.030 |
Why?
|
| Temperature | 1 | 2018 | 290 | 0.030 |
Why?
|
| United States | 2 | 2024 | 12030 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2017 | 50 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2019 | 322 | 0.030 |
Why?
|
| Judgment | 1 | 2017 | 36 | 0.030 |
Why?
|
| Universities | 1 | 2017 | 125 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2017 | 88 | 0.030 |
Why?
|
| Influenza B virus | 1 | 2017 | 102 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 355 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 316 | 0.030 |
Why?
|
| Tasmania | 1 | 2016 | 2 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2018 | 140 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2017 | 156 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 386 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2017 | 145 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 15 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 749 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2018 | 406 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 1209 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 569 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 266 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 1457 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2016 | 204 | 0.030 |
Why?
|
| Fever | 1 | 2018 | 312 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1045 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1376 | 0.030 |
Why?
|
| Pneumonia | 1 | 2018 | 340 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 420 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2016 | 245 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2016 | 637 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 2078 | 0.020 |
Why?
|
| Logistic Models | 1 | 2018 | 1796 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1027 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2017 | 8610 | 0.020 |
Why?
|
| Prevalence | 1 | 2020 | 2693 | 0.020 |
Why?
|
| Child Welfare | 1 | 2013 | 71 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 71 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 963 | 0.020 |
Why?
|
| Exome | 1 | 2017 | 1061 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 240 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2019 | 770 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 889 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4868 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3815 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2900 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2827 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2017 | 907 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 2008 | 27 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 89 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 151 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 234 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 254 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 361 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2008 | 160 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 623 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 1013 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 169 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2007 | 88 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2008 | 399 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3130 | 0.010 |
Why?
|
| Refusal to Participate | 1 | 2003 | 3 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 76 | 0.010 |
Why?
|
| Bias | 1 | 2003 | 149 | 0.010 |
Why?
|
| Confidentiality | 1 | 2003 | 108 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2003 | 394 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12862 | 0.010 |
Why?
|